FDA clears AI software for reading portable MRI brain scans

An AI application that interprets MRI scans of the brain for signs or confirmation of injury has received 510(k) clearance from the FDA.

Hyperfine Research of Guilford, Connecticut, announced the development this week, saying the algorithms work with the company’s portable MRI machine called Swoop and are included in the system’s standard software setup.

The Swoop system is portable, and Hyperfine is positioning the newly approved AI capability as a way to equip clinicians at all levels of expertise with images, interpretative aids and annotations right at the bedside.

The company says the AI helps quickly deliver segmented images along with such measurements as ventricular volume, brain alignment and midline shift (a clinical measure of brain injury).

Announcement here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.